Swedbank AB decreased its position in shares of Colgate-Palmolive Company (NYSE:CL – Free Report) by 5.2% during the first quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 3,963,276 shares of the company’s stock after selling 217,139 shares during the quarter. Swedbank AB’s holdings in Colgate-Palmolive were worth $337,790,000 at the end of the most recent quarter.
Several other hedge funds also recently bought and sold shares of the company. Vanguard Group Inc. increased its stake in Colgate-Palmolive by 1.2% in the 4th quarter. Vanguard Group Inc. now owns 83,947,987 shares of the company’s stock worth $6,633,570,000 after buying an additional 1,026,985 shares in the last quarter. Geode Capital Management LLC boosted its stake in shares of Colgate-Palmolive by 1.4% in the fourth quarter. Geode Capital Management LLC now owns 22,103,901 shares of the company’s stock worth $1,754,657,000 after acquiring an additional 304,426 shares during the period. Morgan Stanley boosted its stake in shares of Colgate-Palmolive by 1.7% in the fourth quarter. Morgan Stanley now owns 19,246,217 shares of the company’s stock worth $1,520,836,000 after acquiring an additional 323,367 shares during the period. Norges Bank purchased a new stake in shares of Colgate-Palmolive during the fourth quarter worth about $861,670,000. Finally, Deutsche Bank AG grew its position in shares of Colgate-Palmolive by 33.9% during the fourth quarter. Deutsche Bank AG now owns 10,845,857 shares of the company’s stock worth $857,040,000 after purchasing an additional 2,746,920 shares in the last quarter. Institutional investors own 80.41% of the company’s stock.
Colgate-Palmolive Price Performance
NYSE CL traded up $1.92 during trading on Tuesday, hitting $95.31. 1,255,789 shares of the stock traded hands, compared to its average volume of 6,190,556. The company has a quick ratio of 0.67, a current ratio of 1.02 and a debt-to-equity ratio of 16.33. Colgate-Palmolive Company has a 12-month low of $74.54 and a 12-month high of $99.33. The firm has a 50-day simple moving average of $89.07 and a 200-day simple moving average of $87.67. The company has a market capitalization of $76.26 billion, a P/E ratio of 37.02, a price-to-earnings-growth ratio of 5.02 and a beta of 0.33.
Colgate-Palmolive Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, August 14th. Shareholders of record on Monday, July 20th will be paid a $0.53 dividend. This represents a $2.12 dividend on an annualized basis and a dividend yield of 2.2%. The ex-dividend date of this dividend is Monday, July 20th. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 82.49%.
Wall Street Analyst Weigh In
A number of research analysts recently commented on the company. JPMorgan Chase & Co. boosted their price target on Colgate-Palmolive from $95.00 to $96.00 and gave the stock an “overweight” rating in a report on Monday, May 4th. TD Cowen reaffirmed a “hold” rating and set a $85.00 price objective on shares of Colgate-Palmolive in a report on Tuesday, March 31st. Wall Street Zen cut shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a research report on Sunday, March 29th. Deutsche Bank Aktiengesellschaft reissued a “buy” rating and issued a $99.00 target price on shares of Colgate-Palmolive in a report on Monday, May 4th. Finally, Royal Bank Of Canada restated an “outperform” rating and set a $102.00 target price on shares of Colgate-Palmolive in a research report on Monday, May 4th. Twelve analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $95.88.
Check Out Our Latest Stock Report on Colgate-Palmolive
Colgate-Palmolive Profile
Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.
The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.
Featured Articles
- Five stocks we like better than Colgate-Palmolive
- 3 Quiet AI Revenue Accelerators With Sales Growth Outpacing Peers
- Top 135 Best Locally Owned BBQ Supply Stores in the U.S., According to Survey [2026]
- Silicon Starvation: Amazon Feasts on Legacy GPUs
- GE Vernova’s Power Surge Turns the Grid Into an AI Trade
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.
-EGX.png){kind=small}
